IHI CORP (IHICY)
(Delayed Data from OTC)
$12.09 USD
+1.50 (14.13%)
Updated Sep 19, 2024 02:19 PM ET
3-Hold of 5 3
C Value C Growth B Momentum C VGM
Income Statements
Fiscal Year end for IHI CORP falls in the month of March .
All items in Millions except EPS data.
3/31/24 | 3/31/23 | 3/31/22 | 3/31/21 | 3/31/20 | |
---|---|---|---|---|---|
Sales | 9,126 | 10,012 | 10,439 | 10,461 | 12,756 |
Cost Of Goods | 8,126 | 7,925 | 8,575 | 8,770 | 10,412 |
Gross Profit | 1,000 | 2,087 | 1,864 | 1,692 | 2,344 |
Selling & Adminstrative & Depr. & Amort Expenses | 1,469 | 1,433 | 1,572 | 1,544 | 1,784 |
Income After Depreciation & Amortization | -469 | 654 | 292 | 148 | 559 |
Non-Operating Income | 24 | -36 | 529 | 160 | -166 |
Interest Expense | 54 | 83 | 41 | 48 | 36 |
Pretax Income | -499 | 536 | 780 | 260 | 357 |
Income Taxes | -51 | 122 | 167 | 100 | 191 |
Minority Interest | 23 | 28 | 25 | 36 | 48 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -447 | 414 | 613 | 159 | 166 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | -471 | 385 | 588 | 123 | 118 |
Depreciation Footnote | 3/31/24 | 3/31/23 | 3/31/22 | 3/31/21 | 3/31/20 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 54 | 1,179 | 1,041 | 902 | 1,159 |
Depreciation & Amortization (Cash Flow) | 523 | 525 | 749 | 754 | 599 |
Income After Depreciation & Amortization | -469 | 654 | 292 | 148 | 559 |
Earnings Per Share Data | 3/31/24 | 3/31/23 | 3/31/22 | 3/31/21 | 3/31/20 |
---|---|---|---|---|---|
Average Shares | 605.30 | 605.08 | 600.90 | 594.26 | 608.55 |
Diluted EPS Before Non-Recurring Items | -0.78 | 0.64 | 0.98 | 0.21 | 0.09 |
Diluted Net EPS (GAAP) | -0.78 | 0.64 | 0.98 | 0.21 | 0.19 |
Fiscal Year end for IHI CORP falls in the month of March .
All items in Millions except EPS data.
6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | |
---|---|---|---|---|---|
Sales | 2,228.24 | 3,066.16 | 2,695.20 | 1,185.79 | 2,178.74 |
Cost Of Goods | 1,749.48 | 2,433.77 | 1,981.40 | 1,957.61 | 1,753.60 |
Gross Profit | 478.76 | 632.39 | 713.80 | -771.83 | 425.14 |
SG&A, R&D, and Dept/Amort Expenses | 326.14 | 393.81 | 349.85 | 368.30 | 356.62 |
Income After SG&A, R&D, and Dept/Amort Expenses | 152.62 | 238.58 | 363.95 | -1,140.13 | 68.52 |
Non-Operating Income | 72.07 | -58.71 | 10.63 | 11.92 | 60.43 |
Interest Expense | 21.93 | -78.80 | 94.60 | 2.11 | 36.01 |
Pretax Income | 202.76 | 258.67 | 279.98 | -1,130.32 | 92.94 |
Income Taxes | 76.37 | -31.28 | 84.49 | -147.98 | 43.51 |
Minority Interest | 7.46 | 3.83 | 5.32 | 5.55 | 8.50 |
Investment Gains/Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | 126.39 | 289.95 | 195.49 | -982.33 | 49.43 |
Extras & Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | 118.93 | 286.11 | 190.18 | -987.89 | 40.92 |
Earnings Per Share Data | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 |
---|---|---|---|---|---|
Average Shares | 605.46 | 605.18 | 604.92 | 605.24 | 606.71 |
Diluted EPS Before Non-Recurring Items | 0.20 | 0.46 | 0.31 | -1.64 | 0.07 |
Diluted Net EPS (GAAP) | 0.20 | 0.47 | 0.31 | -1.63 | 0.07 |